SCHEMBL9760463

SCHEMBL9760463

O=c1[nH]c2ccc(Cc3ccccc3Br)cc2c(=O)n1Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
KDM4E B2RXH2 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
HPGD P15428 3/20 0.58
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 2/20 0.45
HDAC1 Q13547 1/20 0.44
POLB P06746 2/20 0.44
PKM P14618 1/20 0.44
DDR1 Q08345 3/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
MAPK10 P53779 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
FEN1 P39748 1/20 0.43
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7101724 0.81 KMT2A (0.78) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL28932333 0.78 ALDH1A1 (0.68) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL10085009 0.76 KDM4E (0.68) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL6982894 0.74 HPGD (1.00) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL30877025 0.74 HPGD (1.00) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL6218489 0.74 HPGD (0.65) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL9760455 0.73 ALDH1A1 (0.60) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL7098938 0.73 ALDH1A1 (0.63) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL2611397 0.72 KDM4E (0.59) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL17242550 0.72 KDM4E (0.55) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5037829-A Antitumor Activity; Androgen, Estrogen Inhibitors; Suppress The Plasma Elimination Of Retinoids JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-06 US disclosed